These results indicate that the immunostimulatory peptide Hp91 when packaged inside of PLGA-NPs significantly enhances the anti-tumor response to free HER2 peptide in a prophylactic vaccine setting and yielded the longest survival (Figure 3B). This evidence concerns the gene ERBB2 and neoplasm.